Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 16;10(3):e05613.
doi: 10.1002/ccr3.5613. eCollection 2022 Mar.

Intralesional bleomycin for treatment of a recalcitrant wart in an immunocompromised patient: A safe, effective, and underutilized therapy

Tracy Ngo  1 , Hannah Hwang  2 , Bijal Amin  3 , Steven R Cohen  2
Affiliations
Case Reports

Intralesional bleomycin for treatment of a recalcitrant wart in an immunocompromised patient: A safe, effective, and underutilized therapy

Tracy Ngo et al. Clin Case Rep. .

Abstract

Injectable bleomycin is infrequently used for recalcitrant warts despite its efficacy, acceptable safety profile, and high patient satisfaction compared with other treatment modalities. We present an immunocompromised patient with a large recalcitrant wart successfully treated with intralesional bleomycin to provide greater clinical exposure, training, and practice with intralesional bleomycin.

Keywords: bleomycin; human immunodeficiency virus; immunocompromised; verruca vulgaris; wart.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Verruca vulgaris treated with bleomycin. (A) Verruca on left buttock at initial presentation. (B) Recurrence of verruca status post‐slice biopsy and persistence after two months of treatment with imiquimod 3.75% cream. (C) No residual or recurrence of warty activity 5 weeks after treatment with intralesional bleomycin
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Al Aboud A, Nigam P. Wart. StatPearls; 2020. - PubMed
    1. Kruter L, Saggar V, Akhavan A, et al. Intralesional bleomycin for warts: patient satisfaction and treatment outcomes. J Cutan Med Surg. 2015;19(5):470‐476. - PubMed
    1. Dall'oglio F, D'Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence‐based review. Am J Clin Dermatol. 2012;13(2):73‐96. - PubMed
    1. Amer M, Diab N, Ramadan A, Galal A, Salem A. Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. J Am Acad Dermatol. 1988;18(6):1313‐1316. - PubMed
    1. Shumer SM, O’Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol. 1983;9(1):91‐96. - PubMed

Publication types

LinkOut - more resources